Real-world Effectiveness of Airway Clearance Techniques in Children with Cystic Fibrosis

Overview

Journal Eur Respir J

Specialty Pulmonary Medicine

Date 2023 Aug 31

PMID 37652570

Authors

Nicole Filipow

Sanja Stanojevic

Emma Raywood

Harriet Shannon

Gizem Tanriver

Kunal Kapoor

Helen Douglas

Gwyneth Davies

Rachel OConnor

Nicky Murray

Eleanor Main

Affiliations

Soon will be listed here.

Abstract

Background: Cystic fibrosis (CF) is commonly characterised by thick respiratory mucus. From diagnosis, people with CF are prescribed daily physiotherapy, including airway clearance techniques (ACTs). ACTs consume a large proportion of treatment time, yet the efficacy and effectiveness of ACTs are poorly understood. This study aimed to evaluate associations between the quality and quantity of ACTs and lung function in children and young people with CF.

Methods: Project Fizzyo, a longitudinal observational cohort study in the UK, used remote monitoring with electronic pressure sensors attached to four different commercial ACT devices to record real-time, breath-by-breath pressure data during usual ACTs undertaken at home over 16 months in 145 children. ACTs were categorised either as conformant or not with current ACT recommendations based on breath pressure and length measurements, or as missed treatments if not recorded. Daily, weekly and monthly associations between ACT category and lung function were investigated using linear mixed effects regression models adjusting for clinical confounders.

Results: After exclusions, 45 224 ACT treatments (135 individuals) and 21 069 days without treatments (141 individuals) were analysed. The mean±sd age of participants was 10.2±2.9 years. Conformant ACTs (21%) had significantly higher forced expiratory volume in 1 s (FEV) (mean effect size 0.23 (95% CI 0.19-0.27) FEV % pred per treatment) than non-conformant (79%) or missed treatments. There was no benefit from non-conformant or missed treatments and no significant difference in FEV between them (mean effect size 0.02 (95% CI -0.01-0.05) FEV % pred per treatment).

Conclusions: ACTs are beneficial when performed as recommended, but most people use techniques that do not improve lung function. Work is needed to monitor and improve ACT quality and to increase the proportion of people doing effective airway clearance at home.

Citing Articles

Exercise as an airway clearance technique (ExACT) is not simply physical activity.

Saynor Z, Urquhart D Ther Adv Respir Dis. 2024; 18:17534666241292502.

PMID: 39512159 PMC: 11544647. DOI: 10.1177/17534666241292502.

Digital technologies in bronchiectasis physiotherapy services: a survey of patients and physiotherapists in a UK centre.

ONeill K, ONeill B, McLeese R, Chalmers J, Boyd J, Soyza A ERJ Open Res. 2024; 10(3).

PMID: 39371298 PMC: 11163277. DOI: 10.1183/23120541.00013-2024.

Cystic fibrosis year in review 2023.

Swetland D, Savant A Pediatr Pulmonol. 2024; 59(12):3106-3116.

PMID: 39056532 PMC: 11601032. DOI: 10.1002/ppul.27190.

References

Burnham P, Stanford G, Stewart R . Autogenic drainage for airway clearance in cystic fibrosis. Cochrane Database Syst Rev. 2021; 12:CD009595. PMC: 8672941. DOI: 10.1002/14651858.CD009595.pub3. View

Morrison L, Milroy S . Oscillating devices for airway clearance in people with cystic fibrosis. Cochrane Database Syst Rev. 2020; 4:CD006842. PMC: 7197699. DOI: 10.1002/14651858.CD006842.pub5. View

Raywood E, Shannon H, Filipow N, Tanriver G, Stanojevic S, Kapoor K . Quantity and quality of airway clearance in children and young people with cystic fibrosis. J Cyst Fibros. 2022; 22(2):344-351. DOI: 10.1016/j.jcf.2022.09.008. View

Main E, Rand S . Conventional chest physiotherapy compared to other airway clearance techniques for cystic fibrosis. Cochrane Database Syst Rev. 2023; 5:CD002011. PMC: 10161870. DOI: 10.1002/14651858.CD002011.pub3. View

Oberwaldner B, Evans J, Zach M . Forced expirations against a variable resistance: a new chest physiotherapy method in cystic fibrosis. Pediatr Pulmonol. 1986; 2(6):358-67. DOI: 10.1002/ppul.1950020608. View

Cameron R, Office D, Matthews J, Rowley M, Abbott J, Simmonds N . Treatment Preference Among People With Cystic Fibrosis: The Importance of Reducing Treatment Burden. Chest. 2022; 162(6):1241-1254. PMC: 9773229. DOI: 10.1016/j.chest.2022.07.008. View

Gifford A, Mayer-Hamblett N, Pearson K, Nichols D . Answering the call to address cystic fibrosis treatment burden in the era of highly effective CFTR modulator therapy. J Cyst Fibros. 2019; 19(5):762-767. PMC: 7239731. DOI: 10.1016/j.jcf.2019.11.007. View

Main E . Airway clearance research in CF: the 'perfect storm' of strong preference and effortful participation in long-term, non-blinded studies. Thorax. 2013; 68(8):701-2. DOI: 10.1136/thoraxjnl-2012-203054. View

McIlwaine M, Button B, Nevitt S . Positive expiratory pressure physiotherapy for airway clearance in people with cystic fibrosis. Cochrane Database Syst Rev. 2019; 2019(11). PMC: 6953327. DOI: 10.1002/14651858.CD003147.pub5. View

10.

Mayer-Hamblett N, Ratjen F, Russell R, Donaldson S, Riekert K, Sawicki G . Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials. Lancet Respir Med. 2022; 11(4):329-340. PMC: 10065895. DOI: 10.1016/S2213-2600(22)00434-9. View

11.

Main E . What is the best airway clearance technique in cystic fibrosis?. Paediatr Respir Rev. 2013; 14 Suppl 1:10-2. DOI: 10.1016/j.prrv.2013.01.008. View

12.

Wilson L, Morrison L, Robinson K . Airway clearance techniques for cystic fibrosis: an overview of Cochrane systematic reviews. Cochrane Database Syst Rev. 2019; 1:CD011231. PMC: 6353051. DOI: 10.1002/14651858.CD011231.pub2. View

13.

Raywood E, Douglas H, Kapoor K, Filipow N, Murray N, OConnor R . Protocol for Project Fizzyo, an analytic longitudinal observational cohort study of physiotherapy for children and young people with cystic fibrosis, with interrupted time-series design. BMJ Open. 2020; 10(10):e039587. PMC: 7542954. DOI: 10.1136/bmjopen-2020-039587. View

14.

Elborn J . Cystic fibrosis. Lancet. 2016; 388(10059):2519-2531. DOI: 10.1016/S0140-6736(16)00576-6. View

15.

Sermet-Gaudelus I, Mayell S, Southern K . Guidelines on the early management of infants diagnosed with cystic fibrosis following newborn screening. J Cyst Fibros. 2010; 9(5):323-9. DOI: 10.1016/j.jcf.2010.04.008. View

16.

Wilson L, Saldanha I, Robinson K . Active cycle of breathing technique for cystic fibrosis. Cochrane Database Syst Rev. 2023; 2:CD007862. PMC: 9893420. DOI: 10.1002/14651858.CD007862.pub5. View

17.

McIlwaine M, Bradley J, Elborn J, Moran F . Personalising airway clearance in chronic lung disease. Eur Respir Rev. 2017; 26(143). PMC: 9488523. DOI: 10.1183/16000617.0086-2016. View

18.

Ward N, Ward B, Stiller K, Kenyon A, Holland A . Development of a device to measure adherence and pressure characteristics of positive expiratory pressure therapies used by adults with cystic fibrosis. Physiother Theory Pract. 2020; 38(10):1469-1477. DOI: 10.1080/09593985.2020.1858465. View

19.

Quanjer P, Stanojevic S, Cole T, Baur X, Hall G, Culver B . Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012; 40(6):1324-43. PMC: 3786581. DOI: 10.1183/09031936.00080312. View

20.

Filipow N, Main E, Tanriver G, Raywood E, Davies G, Douglas H . Exploring flexible polynomial regression as a method to align routine clinical outcomes with daily data capture through remote technologies. BMC Med Res Methodol. 2023; 23(1):114. PMC: 10176913. DOI: 10.1186/s12874-023-01942-4. View